Radiofrequency ablation for treatment-naïve T1 lung tumors

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

IntRadiology6716

New Member
7+ Year Member
Joined
Jul 6, 2014
Messages
1
Reaction score
0
Ridge Carole A, Silk Mikhail, Petre Elena N, et al. Radiofrequency Ablation of T1 Lung Carcinoma: Comparision of Outcomes for First Primary, Metachronous, and Synchronous Lung Tumors. JVIR July 2014.

Summary: 29 patients with treatment-naïve T1 first primary, metachronous, or synchronous lung tumors were treated with frequency ablation. CT or PET surveillance was completed at a median of 28 months, and technical success and effectiveness at 1, 3, and 5 years calculated according to stage and tumor status. 97% technical success and effectiveness reported, with the lowest local progression rate seen with metachronous (14%) and synchronous (0%) versus first primary (45%). Survival outcomes were similar for the 3 groups. The study suggests “RF ablation is an appropriate treatment option for patients with metachronous or synchronous lung tumors who are ineligible for surgery, and those with de novo lung tumors.”

Are providers you have interacted with utilizing radiofrequency ablation for Stage T1 lung tumors? What other factors make them candidates (co-morbidity, metachronous, synchronous, de novo?).

Members don't see this ad.
 
Crap...This is basically the project that I was going to finish in September.
 
Top